| Entry |
|
|---|
| Name |
Lonidamine (INN);
Doridamina (TN) |
|---|
| Formula |
C15H10Cl2N2O2
|
|---|
| Exact mass |
320.0119
|
|---|
| Mol weight |
321.15
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic |
|---|
| Target |
|
|---|
| Pathway |
| hsa05230 | Central carbon metabolism in cancer |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX07 Lonidamine
D07257 Lonidamine (INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Phosphotransferase
HK
D07257 Lonidamine (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C8x C 22.0500 -19.9500
2 C8x C 22.0500 -18.5500
3 C8x C 23.3100 -17.8500
4 C8y C 24.5000 -18.5500
5 C8y C 24.5000 -19.9500
6 C8x C 23.3100 -20.6500
7 N4y N 25.8300 -18.1300
8 N5x N 26.6700 -19.2500
9 C8y C 25.8300 -20.3700
10 C6a C 26.2500 -21.7000
11 O6a O 27.6500 -21.9800
12 O6a O 25.3400 -22.7500
13 C1b C 26.2500 -16.8000
14 C8y C 27.6499 -16.7847
15 C8y C 28.3699 -18.0007
16 C8x C 29.7698 -17.9854
17 C8y C 30.4565 -16.7653
18 C8x C 29.7365 -15.5493
19 C8x C 28.3366 -15.5647
20 X Cl 31.8500 -16.8053
21 X Cl 28.3518 -19.3828
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 5 9 1
11 9 10 1
12 10 11 1
13 10 12 2
14 7 13 1
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 14 19 1
22 17 20 1
23 15 21 1
|
|---|
